Published On: May 15th, 2021Categories: News

BioLoomics is forming a Scientific Advisory Board (SAB) to bring together diverse experts to bolster our mission to produce drug discovery assays and the first biosensing biologics with enhanced specificity and efficacy.

We are proud to announce that Dr. Michael Stowell is our first Scientific Advisory Board member. His expertise in the structural biology of channels and receptors will bring important insights to our drug development pipelines.

Michael Stowell is a professor at the University of Colorado, Boulder in the department of Molecular, Cellular and Developmental Biology. In addition to his professorship, Dr. Stowell is a co-founder of InRedox and a co-founder and CSO of AmideBio. Welcome aboard Dr. Stowell!